GLP-1 drugsReview

GLP-1 Receptor Agonists in Diabetic Lower Extremity Peripheral Artery Disease: From Mechanisms to Clinical Practice

Figure from British Journal of Hospital Medicine — Pan et al.

British Journal of Hospital Medicine

The paper

Jie Pan, Chengnan Guo, Chengnan Guo,

Qiuwei Huang, Yikai Zhang, Yimin Shen, Caiyun Guo,

Second Affiliated Hospital of Zhejiang University · Ningbo University

British Journal of Hospital Medicine · 1 Sep 2026

doi.org/10.31083/bjhm55884 PubMed 42812078

GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026